Case Study: Nimbus Therapeutics accelerates small molecule drug discovery with Pluto Bio

Nimbus Therapeutics Accelerated small molecule drug discovery

Nimbus Therapeutics, a small molecule drug discovery biotech company, faced challenges in analyzing and interpreting its vast multi-omics datasets. The complexity of traditional bioinformatics tools created bottlenecks, requiring specialized expertise and making it difficult to share critical findings across teams. To overcome this, they implemented the multi-omics analysis platform from Pluto Bio.

Using Pluto Bio's no-code online workspace, Nimbus biologists could independently perform complex analyses and create clear visualizations. This solution accelerated their time-to-insight from days or weeks to just hours, enabling faster decision-making in the lead optimization process. The platform also fostered enhanced collaboration and helped Nimbus reduce costs by minimizing the need for outsourced bioinformatics expertise.

Nimbus Therapeutics

Scott Boiko

Director Translational Medicine